Paul Tocci
Urology · Ft Lauderdale, FLNPI 1699856211
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.9% of the total across 95 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 18.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $909 and has fallen 78.0% since, to $200 in 2023. That places this record below the midpoint for urology clinicians in FL, where the typical reported total is $3,881.
Across 95 payments — averaging $27.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$468
- Endo Pharmaceuticals Inc.$460
- Johnson & Johnson$323
- Myriad Genetic Laboratories, Inc.$289
- Tolmar Pharmaceuticals, Inc.$221
- Boston Scientific$113
- plus $720 from 15 others
What the payments were for
- Food & beverage$2,51397%
- Education$803%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 6 | $468 |
| Endo Pharmaceuticals Inc. | 29 | $460 |
| Johnson & Johnson | 7 | $323 |
| Myriad Genetic Laboratories, Inc. | 5 | $289 |
| Tolmar Pharmaceuticals, Inc. | 11 | $221 |
| Boston Scientific | 5 | $113 |
| Olympus America Inc. | 1 | $107 |
| Bayer | 4 | $90 |
| Pfizer | 4 | $83 |
| Coloplast | 4 | $78 |
| Ferring Pharmaceuticals Inc. | 4 | $67 |
| Dentsply IH Inc. | 2 | $52 |
| Myovant Sciences Inc. | 4 | $51 |
| Teleflex LLC | 1 | $40 |
| Convatec Inc. | 2 | $34 |
| Acerus Pharmaceuticals Corporation | 1 | $24 |
| AstraZeneca | 1 | $23 |
| Antares Pharma, Inc. | 1 | $20 |
| Blue Earth Diagnostics | 1 | $19 |
| Clarus Therapeutics Inc. | 1 | $18 |
| RGH Enterprises LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XTANDI$405
- Erleada$122
- Dornier MedTech$107
How this compares
$2,593 in reported general payments places this provider in the 35th percentile of 935 urology providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 54 | $875 |
| Dutasteride | 18 | $517 |
Paid to pharmacies, not to this prescriber.
Other urology in Ft Lauderdale
- Paul PeritoCoral Gables$3.6M
- Scott SellingerTallahassee$2.3M
- Mark Anthony GonzalgoMiami$1M
- Edward GheilerHialeah$655K
- Rolando RiveraNaples$437K
- Matthew ErcolaniVenice$416K
- Olubayo TojuolaOrlando$283K
- Juan SuarezCoral Gables$276K
- Michael McDonaldCelebration$272K
- Raymond PakJacksonville$251K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.